While our data presented in this paper provides evidence for TRIB1 altering macrophage phenotypes (pro- vs. anti-inflammatory) both in murine metabolic tissues and human monocyte-derived macrophages, further mechanistic studies are required to elucidate the full impact of these TRIB1-mediated changes on prostate cancer cells. This evidence concerns the gene TRIB1 and prostate cancer.